Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,331 INR | -1.85% | -0.23% | -1.85% |
Apr. 16 | Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution | MT |
Mar. 28 | Caplin Point Unit Receives US FDA Nod for Eye Treatment Medication | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.85% | 1.23B | |
+20.61% | 43.18B | |
+20.67% | 22.59B | |
+15.45% | 14.56B | |
+13.94% | 13.54B | |
+43.35% | 11.5B | |
-8.37% | 6.93B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.36B |
- Stock Market
- Equities
- CAPLIPOINT Stock
- News Caplin Point Laboratories Limited
- Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution